UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer

Gynecologic oncology, 2021-02, Vol.160 (2), p.418-426

2021

Volltextzugriff (PDF)

Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy

Clinical cancer research, 2005-01, Vol.11 (1), p.361-369

2005

Volltextzugriff (PDF)

CpG oligodeoxynucleotide enhances tumor response to radiation

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5074-5077

2004

Volltextzugriff (PDF)

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

Cancer chemotherapy and pharmacology, 2014-05, Vol.73 (5), p.931-941

2014

Volltextzugriff (PDF)

EP-100 + paclitaxel to overcome taxane resistance in patients with recurrent LHRH-receptor expressing ovarian cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5582-5582

2015

Volltextzugriff (PDF)

A phase I study of EP-100, a luteinizing hormone releasing hormone (LHRH) ligand conjugated to a synthetic cytolytic peptide in patients with advanced refractory LHRH- receptor (R)-expressing tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.3060-3060

2012

Volltextzugriff (PDF)

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission

Blood, 2008-11, Vol.112 (11), p.1948-1948

2008

Volltextzugriff (PDF)

Impact on Quality of Life of Postconsolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myelogenous Leukemia

Blood, 2007-11, Vol.110 (11), p.4381-4381

2007

Volltextzugriff (PDF)

The protective role of the immunomodulator AS101 against chemotherapy‐induced alopecia studies on human and animal models

International journal of cancer, 1996-01, Vol.65 (1), p.97-103

1996

Volltextzugriff (PDF)

Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia

The New England journal of medicine, 1977-06, Vol.296 (26), p.1485

1977

Volltextzugriff (PDF)

Introduction: Gay German History: Future Directions?

Journal of the history of sexuality, 2007, Vol.17 (1), p.1-10

Whisnant, Clayton John

2007

Volltextzugriff (PDF)

Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule

Cancer research (Chicago, Ill.), 1988-08, Vol.48 (16), p.4706-4710

1988

Volltextzugriff (PDF)

Correction of severe combined immunodeficiency by fetal liver cells

The New England journal of medicine, 1976-05, Vol.294 (20), p.1076

1976

Volltextzugriff (PDF)

An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b

The Journal of immunology (1950), 1972-06, Vol.108 (6), p.1551

1972

Volltextzugriff (PDF)

Splenectomy vs. alpha interferon: A randomized study in patients with previously untreated hairy cell leukemia

American journal of hematology, 1992-09, Vol.41 (1), p.13-18

1992

Volltextzugriff (PDF)

Enteric Bacteria Cross-Reactive with Neisseria meningitidis Groups A and C and Diplococcus pneumoniae Types I and III

Infection and Immunity, 1972-11, Vol.6 (5), p.651-656

1972

Volltextzugriff (PDF)

Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis

Archives of otolaryngology--head & neck surgery, 1988-10, Vol.114 (10), p.1163

1988

Volltextzugriff (PDF)

Efficacy of Human Lymphoblastoid Interferon in the Therapy of Resistant Condyloma Acuminata

Obstetrics and gynecology (New York. 1953), 1986-05, Vol.67 (5), p.643-651

1986

Volltextzugriff (PDF)

A randomized comparison of two doses of human lymphoblastoid interferon-α in hairy cell leukemia

Blood, 1991-12, Vol.78 (12), p.3133-3141

1991

Volltextzugriff (PDF)

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

Pediatric research, 1973-03, Vol.7 (3), p.103-110

1973

Volltextzugriff (PDF)

Interferons in the treatment of human papillomavirus diseases

Cancer and metastasis reviews, 1986-01, Vol.5 (2), p.139-165

1986

Volltextzugriff (PDF)

Interferon alpha-n1 (wellferon) for refractory genital warts: Efficacy and tolerance of low dose systemic therapy

Antiviral research, 1988-11, Vol.10 (1), p.41-57

1988

Volltextzugriff (PDF)

Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies

Pediatric research, 1973-03, Vol.7 (3), p.103-110

1973

Volltextzugriff (PDF)

Hamburg's gay scene in the era of family politics, 1945–1969

Whisnant, Clayton John

2001

Volltextzugriff (PDF)

Pharmaco-epidemiology—Drugs, arthritis, and neoplasms: industry contribution to the data

The American journal of medicine, 1985-01, Vol.78 (1), p.69-76

1985

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(69)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer

Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy

CpG oligodeoxynucleotide enhances tumor response to radiation

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors

EP-100 + paclitaxel to overcome taxane resistance in patients with recurrent LHRH-receptor expressing ovarian cancer

A phase I study of EP-100, a luteinizing hormone releasing hormone (LHRH) ligand conjugated to a synthetic cytolytic peptide in patients with advanced refractory LHRH- receptor (R)-expressing tumors

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission

Impact on Quality of Life of Postconsolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myelogenous Leukemia

The protective role of the immunomodulator AS101 against chemotherapy‐induced alopecia studies on human and animal models

Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia

Introduction: Gay German History: Future Directions?

Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule

Correction of severe combined immunodeficiency by fetal liver cells

An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b

Splenectomy vs. alpha interferon: A randomized study in patients with previously untreated hairy cell leukemia

Enteric Bacteria Cross-Reactive with Neisseria meningitidis Groups A and C and Diplococcus pneumoniae Types I and III

Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis

Efficacy of Human Lymphoblastoid Interferon in the Therapy of Resistant Condyloma Acuminata

A randomized comparison of two doses of human lymphoblastoid interferon-α in hairy cell leukemia

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

Interferons in the treatment of human papillomavirus diseases

Interferon alpha-n1 (wellferon) for refractory genital warts: Efficacy and tolerance of low dose systemic therapy

Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies

Hamburg's gay scene in the era of family politics, 1945–1969

Pharmaco-epidemiology—Drugs, arthritis, and neoplasms: industry contribution to the data

Suchergebnisse filtern